In this episode, Martin discusses the recent move in AMD's stock price and examines the factors he believes are driving investor sentiment. He also shares his perspective on Nvidia's role in AI infrastructure, comments on SpaceX's GPU-related strategy, and reviews the latest clinical trial developments at Tenax Therapeutics (TENX), discussing their potential implications for the company and his broader investment outlook.

In this episode, Martin discusses why he believes Palantir could face the same long-term competitive pressures affecting the broader software industry as artificial intelligence continues to evolve. He explains the reasoning behind his outlook for enterprise software, then analyzes Intel and Tenax Therapeutics (TENX), examining their businesses, valuations, competitive positions, and the key factors influencing his current investment thesis on each company.

In this episode, Martin discusses his view that advances in artificial intelligence could dramatically reshape the software industry over the next several years. He explains why he believes many traditional software companies may face increasing competitive pressure from AI-driven products and automation, examining the potential impact on business models, margins, valuations, and long-term investment opportunities across the technology sector.

In this episode, Martin explains why he believes making smaller, disciplined bets can lead to better long-term trading performance. He discusses position sizing, risk management, expected returns, and the psychological benefits of limiting exposure, while outlining how consistent capital preservation and disciplined decision-making can improve investment outcomes over time.

In this episode, Martin explains the core principles behind his trading strategy, including how he incorporates technical analysis alongside fundamental research to identify trading opportunities and manage risk. He discusses chart patterns, timing, and position management before sharing his views on Tenax Therapeutics and Amazon, analyzing their businesses, valuations, and the factors influencing his current investment outlook.

In this episode, Martin reflects on a short position in Palantir that moved against him and discusses the lessons he learned from the trade. He also examines whether Anthropic's advances in artificial intelligence could pose a competitive threat to Palantir's business, analyzing the companies' strategies, competitive positioning, and the broader impact of AI on enterprise software and data analytics.

This compilation brings together Martin’s discussions on capital allocation, active investing, and market cycles. Across a range of clips, he explains why he believes actively deploying capital into high-conviction opportunities can outperform passive investing during periods of market excess and subsequent corrections. The episode also covers portfolio management, valuation, risk control, and the principles he believes are most important for navigating speculative markets and preserving long-term returns.

In this episode, Martin discusses adding to one of his investment positions and explains the reasoning behind increasing his exposure. He also analyzes Bloom Energy, Adicet Bio, Google, and Thermo Fisher Scientific (TMO), examining each company's business, competitive position, valuation, and long-term prospects while sharing the factors that shape his current investment outlook.

In this episode, Martin discusses receiving another margin call and explains how market volatility and leveraged positions can affect portfolio management. He also shares his perspective on Micron's recent decline, analyzes Amazon and Nebius, and reviews a clinical trial involving Tenax Therapeutics, discussing the implications for the company and the factors influencing his investment outlook across each of these names.

In this episode, Martin shares his outlook for the broader market and discusses the trends he believes investors should watch in the coming months. He also explains why he views Meta as an attractive investment opportunity and introduces the Kelly Criterion, outlining how the framework can be used to determine position sizes and allocate capital more effectively while balancing expected returns and risk.